Navigation Links
Economic Growth In Latin America Fueling Strong Revenue Growth For Interventional Cardiology Devices
Date:5/2/2013

TORONTO, May 2, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, favorable demographics and growing economies are the main factors spurring rising revenues in the Latin American interventional cardiology (IC) device market. Economic growth is contributing to increased public reimbursement coverage, which is essential in driving adoption of IC devices, especially more expensive drug-eluting stents (DES) and bioresorbable vascular scaffolds (BVS).

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

Unfortunately, reimbursement also has its downsides. In Brazil, public reimbursement for DES is expected to be introduced by mid-2013. As a result, the prices of DES and bare-metal stents (BMS) will be cut significantly as the government pressures manufacturers to lower their prices in order to accommodate government health care budgets. These cuts will have a strong impact in the short term because growth in DES unit sales will not yet be able to offset the price cuts. Because Brazil is the largest market in Latin America, dampened revenues in the country as a result of the price cuts will affect overall market trends.

"Drops in prices will impact short-term revenues," said MRG Analyst Mirel Giugaru . "The silver lining is that lower prices will ultimately improve the affordability of IC devices, which will drive adoption and lead to strong revenue growth in the long term."

Once BVS gain public reimbursement approval around 2016 to 2017, these devices will follow a similar adoption pattern as DES. The premium prices of BVS and lack of long-term clinical data will initially limit their uptake, but as prices decrease drastically to be more in line with the cost of DES as well as public health care budgets, BVS penetration will rise quickly at the expense of DES.  

Unlike other emerging markets, such as China and India, multinational competitors such as Boston Scientific, Abbott Laboratories and Medtronic face very little competition from local competitors in Latin America. As a result, they benefit from less competitive pricing pressure as well as equal footing in terms of approval times and physician loyalty.

Millennium Research Group's Latin American Markets for Interventional Cardiology Devices 2013 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters and accessory devices in Argentina, Brazil, Colombia and Mexico. Supplemental country coverage is also available for Chile, Peru, and Venezuela, as well as in aggregate for the rest of the Latin American countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net

 


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting
2. Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare Spending
3. CHPA Statement on PSE Economic Study By AEI Fellow Alex Brill
4. Precision Health Economics Adds Executive Sales And Marketing Leader
5. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
6. Philips transforms care to address the economic challenges faced by radiology departments and radiologists worldwide
7. Boston Healthcare Expands Health Economics, Pricing, and Reimbursement Consulting Practice in Asia
8. Frost & Sullivan: Respirator Manufacturers to Develop Innovative Solutions to Overcome Economic Challenges in North America
9. Brazilian Healthcare Industry Thrives in Favorable Socioeconomic Environment, Finds Frost & Sullivan
10. Ingenuity Systems Named 2013 World Economic Forum Technology Pioneer
11. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):